Integrum is expanding in US
Integrum, the world leader in osseointegrated prosthetics for amputees was excited to announce its inaugural participation as an exhibitor at the 2019 Amputee Coalition’s National Conference in San Antonio, Texas held July 25th-27th, 2019.
Integrum has been a gold sponsor to the American Amputee Coalition since January 2019. The American Amputee Coalition is a non-profit organization with more than 500 000 members dedicated to enhancing the quality of life for amputees and their families through support, education and advocacy.
The Amputee Coalition’s National Conference provided Integrum with a strategic opportunity to promote existing centers and now six additional hospitals starting to recruit patients for treatment with the OPRA Implant System. Three of these centers are major University Hospitals similar to UCSF, two are minor University Hospitals and one is a leading private hospital. This will make it easier for people to receive osseointegration in the U.S using the OPRA System, since the centers are strategically located across the US (see map) and is eliminating the need to travel abroad. More than 1200 amputees participated in the meeting and many showed a great interest in Integrum’s products.
Over the past years the introduction and consideration of osseointegration as a viable option for specific amputees within the limb loss community has continued to establish itself in the U.S. market. This rapidly developing treatment for amputee care gained a considerable boost when the FDA awarded Integrum an HDE approval for the OPRA System in July 2015. The subsequent years have seen the Department of Defense and the University of California San Francisco complete the majority of procedures with the OPRA System since that time. The work completed at these centers has helped provide valuable insight and given Integrum the time to enhance the surgical approach and refine rehabilitation protocols to facilitate hospital acceptance of this option for Limb Loss Restoration in the challenging and evolving U.S. healthcare system. Integrum’s hard work over the last years to expand the number of hospitals recruiting patients the US is now starting to pay off.
The information in this press release is information that Integrum AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the contact person set out below, at 8:00 CET on July 31, 2019.
Integrum AB is listed on Nasdaq First North in Stockholm. Erik Penser is the Company´s Certified Adviser.
For further information contact
María López, CEO. Mobile: +46 708 46 10 69, Email: firstname.lastname@example.org
Erik Penser Bank AB, Certified Adviser can be reached at +46 8 463 8000 or email@example.com
Integrum provides innovative solutions for bone-anchored prostheses. Integrum’s OPRA implant system improves quality of life for amputees through higher prosthetic functionality, improved comfort and improved mobility. With 20 years’ experience from 500 surgeries in 14 countries, Integrum has today a leading position in bone anchored protheses. The company is publicly listed at Nasdaq Firth North